STOCK TITAN

Slide Insurance CRO sells 11,374 shares at $24.62

Slide’s chief risk officer exercised and sold 11,374 shares under a pre-set Rule 10b5-1 trading plan, leaving a significant stock option position outstanding.

(Neutral)
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Slide Insurance Holdings, Inc. (SLDE) reported that Chief Risk Officer Matthew Paul Larson executed an option exercise-and-sale transaction on September 3, 2026. He exercised options for 11,374 shares of common stock at $1.38 per share and sold the same 11,374 shares at a weighted average price of $24.62 per share, with sale prices ranging from $24.50 to $24.87, in a transaction reported as occurring in the open market or a private transaction. The exercise and sale were carried out under a Rule 10b5-1 trading plan adopted on May 4, 2026. After the transaction, Larson held 38,874 stock options; a related disclosure states that, of 50,248 stock options reported, 36,498 are vested and exercisable and the remaining 13,750 are scheduled to vest on July 14, 2027, with the options expiring on February 24, 2032.

Positive

  • None.

Negative

  • None.
Insider LARSON MATTHEW PAUL
Role Chief Risk Officer
Sold 11,374 shs ($280K)
Approx. gross sale proceeds $280K
Approx. exercise cost $16K
Approx. pre-tax spread $264K
Type Security Shares Price Value
Exercise Stock Option (Right to Buy) F1, F3 11,374 $0.00 $0.00
Exercise Common Stock 11,374 $1.38 $16K
Sale Common Stock F1, F2 11,374 $24.62 $280K
Holdings After Transaction: Stock Option (Right to Buy) — 38,874 contracts (Direct); Common Stock — 0 shares (Direct)
Footnotes (3)
  1. F1. Exercised and sold pursuant to a 10b5-1 trading plan adopted by the Reporting Person on May 4, 2026.
  2. F2. Represents the weighted average price of the shares sold. The prices of the shares sold pursuant to the transactions ranges from $24.50 to $24.87 per share. The Reporting Person, upon request, will provide the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price.
  3. F3. Of the 50,248 stock options reported herein, 36,498 are vested and exercisable. The remaining 13,750 vest on July 14, 2027.
Shares exercised 11,374 shares Options exercised for common stock on September 3, 2026
Option exercise price $1.38 per share Exercise price for options converted into common stock
Shares sold 11,374 shares Common stock sold on September 3, 2026 after option exercise
Weighted average sale price $24.62 per share Weighted average of sale prices from $24.50 to $24.87 per share
Options outstanding after transaction 38,874 options Stock options held following the reported exercise
Total options referenced 50,248 stock options Stock options referenced in a related disclosure note
Vested and exercisable options 36,498 options Portion of referenced options that are vested and exercisable
Unvested options vesting July 14, 2027 13,750 options Remaining options scheduled to vest on July 14, 2027
Rule 10b5-1 trading plan regulatory
"Exercised and sold pursuant to a 10b5-1 trading plan adopted by the Reporting Person"
A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.
weighted average price financial
"Represents the weighted average price of the shares sold."
Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.
vested and exercisable financial
"Of the 50,248 stock options reported herein, 36,498 are vested and exercisable."

FAQ

What insider transaction did SLDE’s chief risk officer report on September 3, 2026?

He exercised options for 11,374 shares of Slide Insurance Holdings, Inc. common stock at $1.38 per share and sold 11,374 shares the same day at a weighted average price of $24.62 per share, with prices ranging from $24.50 to $24.87.

Was the SLDE insider transaction made under a Rule 10b5-1 trading plan?

Yes. The exercise and sale were “exercised and sold pursuant to a 10b5-1 trading plan” that Matthew Paul Larson adopted on May 4, 2026, indicating the trades were pre-arranged under that plan.

How many SLDE shares did the insider sell, and at what price range?

He sold 11,374 shares of Slide Insurance Holdings, Inc. common stock at a weighted average price of $24.62 per share. A disclosure states the sale prices ranged from $24.50 to $24.87 per share.

What stock options does the SLDE chief risk officer retain after this Form 4 transaction?

After the reported exercise, he held 38,874 stock options. A related disclosure notes that, of 50,248 stock options reported, 36,498 are vested and exercisable and 13,750 are scheduled to vest on July 14, 2027.

What is the exercise price and expiration date of the SLDE options involved?

The options exercised to acquire Slide Insurance Holdings, Inc. shares had an exercise price of $1.38 per share and an expiration date of February 24, 2032, as disclosed in the Form 4 data.

What role does Matthew Paul Larson hold at SLDE in this Form 4?

Matthew Paul Larson is identified as the Chief Risk Officer of Slide Insurance Holdings, Inc. in the Form 4 reporting these option exercise and share sale transactions.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
X
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
LARSON MATTHEW PAUL

(Last)(First)(Middle)
4221 W BOY SCOUT BLVD
SUITE 200

(Street)
TAMPA FLORIDA 33607

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
Slide Insurance Holdings, Inc. [ SLDE ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
Chief Risk Officer
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
09/03/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock09/03/2026M11,374A$1.3811,374D
Common Stock09/03/2026S11,374(1)D$24.62(2)0D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Stock Option (Right to Buy)$1.3809/03/2026M(1)11,374 (3)02/24/2032Common Stock11,374$038,874D
Explanation of Responses:
1. Exercised and sold pursuant to a 10b5-1 trading plan adopted by the Reporting Person on May 4, 2026.
2. Represents the weighted average price of the shares sold. The prices of the shares sold pursuant to the transactions ranges from $24.50 to $24.87 per share. The Reporting Person, upon request, will provide the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price.
3. Of the 50,248 stock options reported herein, 36,498 are vested and exercisable. The remaining 13,750 vest on July 14, 2027.
/s/ Anastasios Omiridis, Attorney-in-Fact for Matthew Larson09/08/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Keep reading